share_log

8-K: Current report

8-K:臨時報告書

SEC ·  07/23 15:30

Moomoo AIのまとめ

FOXO Technologies Inc., a Delaware corporation listed on the NYSE American under the ticker FOXO, has completed the acquisition of Myrtle Recovery Centers, Inc. The acquisition was finalized through a Stock Exchange Agreement with Myrtle and Rennova Health, Inc., with FOXO Technologies acquiring 98.4% of Myrtle's issued and outstanding shares. The transaction, valued at $500,000, was settled by issuing shares of FOXO's Class A Common Stock based on the volume weighted average price prior to the closing date, with a cap at 19.99% of FOXO's outstanding Class A shares. The deal, which closed on June 14, 2024, also includes provisions for adjusting the purchase price based on Myrtle's EBITDA as indicated in their audited financial statements. Additionally, FOXO Technologies reported the...Show More
FOXO Technologies Inc., a Delaware corporation listed on the NYSE American under the ticker FOXO, has completed the acquisition of Myrtle Recovery Centers, Inc. The acquisition was finalized through a Stock Exchange Agreement with Myrtle and Rennova Health, Inc., with FOXO Technologies acquiring 98.4% of Myrtle's issued and outstanding shares. The transaction, valued at $500,000, was settled by issuing shares of FOXO's Class A Common Stock based on the volume weighted average price prior to the closing date, with a cap at 19.99% of FOXO's outstanding Class A shares. The deal, which closed on June 14, 2024, also includes provisions for adjusting the purchase price based on Myrtle's EBITDA as indicated in their audited financial statements. Additionally, FOXO Technologies reported the issuance of 80,600 shares to Smithline Family Trust II and 1,023,629 shares to RHI as part of the Myrtle acquisition. Furthermore, the company will issue 1,108,755 shares of Class A Common Stock related to a senior note. These securities were issued under exemptions from registration requirements, and no sales commissions were paid in these transactions. The company's board of directors approved the closing of the Myrtle SEA on July 17, 2024, and the report was signed by Interim CEO Mark White on July 23, 2024.
NYSE Americanに上場するデラウェア州のFOXO Technologies Incは、Stock Exchange Agreementを通じてRennova Health, Inc.とMyrtle Recovery Centers, Inc.の買収を完了しました。FOXO Technologiesは、Myrtleの発行済み株式のうち98.4%を取得し、取引額は$500,000でした。取引額は、取引日前日の出来高加重平均価格に基づいてFOXOのClass A Common Stockの株式の19.99%を上限として発行されました。この取引は、2024年6月14日に完了し、Myrtleの...すべて展開
NYSE Americanに上場するデラウェア州のFOXO Technologies Incは、Stock Exchange Agreementを通じてRennova Health, Inc.とMyrtle Recovery Centers, Inc.の買収を完了しました。FOXO Technologiesは、Myrtleの発行済み株式のうち98.4%を取得し、取引額は$500,000でした。取引額は、取引日前日の出来高加重平均価格に基づいてFOXOのClass A Common Stockの株式の19.99%を上限として発行されました。この取引は、2024年6月14日に完了し、Myrtleの監査済み財務諸表に示されているEBITDAに基づいて購入価格を調整する規定も含まれています。さらに、FOXO Technologiesは、Myrtle買収の一環として、80,600株をSmithline Family Trust IIに、1,023,629株をRHIに発行したことを報告しました。このほかにも、同社はSenior Noteに関連するClass A Common Stock 1,108,755株を発行します。これらの証券は登録要件からの除外の下に発行され、これらの取引には営業手数料は支払われませんでした。同社の取締役会は2024年7月17日にMyrtle SEAの完了を承認し、レポートは2024年7月23日にInterim CEO Mark Whiteによって署名されました。
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報